BHIC

BioScience Health Innovations I

Price Chart

Latest Quote

$4.35

+0.19 (+4.49%)

Current Price

Previous Close	$4.16
Open	$4.11
Day High	$4.81
Day Low	$4.11
Volume	1,000

Fetched: 2026-06-05T06:34:42

Stock Information

Shares Outstanding	11.42M
Total Debt	$460K
Cash Equivalents	$1.15M
Revenue	$5.21M
Net Income	$-15K
Sector	Healthcare
Industry	Pharmaceutical Retailers
Market Cap	$49.62M
P/E Ratio	144.89
EPS (TTM)	$0.03
Exchange	OID

🌐 Visit Website

📊 Comprehensive Analysis

Company Data

Enterprise Value	$48.94M
Sales	$5.21M
Income	$-15K
Book/sh	$0.15
Cash/sh	$0.10

Financial Ratios

Quick Ratio	1.89
Current Ratio	3.40
Debt/Eq	27.33

Returns & Margins

ROA	2.09%
ROE	-0.99%
Gross Margin	54.30%
Operating Margin	-30.62%
Profit Margin	-0.28%

Ownership

Insider Ownership	44.26%
Insider & Institutional transactions data not available

Valuation Ratios

P/S	9.52
P/B	29.37

Analyst Data

Recommendation

none

Technical Indicators

SMA20	$4.24
SMA50	$3.67
SMA200	$3.86
RSI	52.34
ATR	0.6653

Shares Float	6.11M
Volatility	1.33
Rel Volume	0.27

Performance History

Week	+4.43%
Month	+8.39%
Quarter	+8.67%
6 Months	+8.67%
YTD	+8.67%
Year	-91.64%
3 Years	-91.64%
10 Years	+97.57%

Stock Score: ⭐ Premium

Based on debt, profitability, growth, and cash flow metrics

⭐ Premium Feature

Recent Price History

Date	Close	Volume
2026-06-04	$4.35	2,200
2026-06-03	$4.16	9,489
2026-06-02	$4.09	6,700
2026-06-01	$4.04	31,925
2026-05-29	$4.06	14,286
2026-05-28	$4.16	6,904
2026-05-27	$4.25	2,800
2026-05-26	$5.22	7,804
2026-05-22	$4.06	4,400
2026-05-21	$4.78	5,100
2026-05-20	$4.20	1,400
2026-05-19	$4.12	500
2026-05-18	$4.10	6,500
2026-05-15	$4.05	3,712
2026-05-14	$4.15	7,950
2026-05-13	$4.04	38,050
2026-05-12	$4.10	2,500
2026-05-11	$4.05	1,600
2026-05-08	$4.71	5,600
2026-05-07	$4.06	4,099
2026-05-06	$4.00	3,326
2026-05-05	$4.01	2,451

About BioScience Health Innovations I

BioScience Health Innovations, Inc. operates as a health and wellness innovation company focuses on mitochondrial health science, advanced peptide delivery, and metabolic care in the United States. It offers nutritional supplements, peptides, and bioactive compounds through its core technology Mineral Oxide Delivery System, as well as provides Oracle NetSuite, an accounting and financial reporting system. The company also provides services, including testosterone and hormonal Optimization, NAD+ and cellular health, and platform licensing and peptide delivery. It sells its products through Amazon platform; and direct-to-consumer. The company was formerly known as Nowtransit Inc and changed its name to BioScience Health Innovations, Inc. in February 2025. BioScience Health Innovations, Inc. is based in Bluffdale, Utah.

📰 Latest News

Calculating The Fair Value Of Boustead Heavy Industries Corporation Berhad (KLSE:BHIC)

Simply Wall St. • 2026-01-21T22:56:23Z

Boustead Heavy Industries Corporation Berhad Second Quarter 2025 Earnings: RM0.004 loss per share (vs RM0.045 profit in 2Q 2024)

Simply Wall St. • 2025-09-01T02:57:39Z

Period:

Income Statement (Annual)

Metric	2024-12-31	2023-12-31	2022-12-31	2022-08-31
Revenue
Reconciled Cost Of Revenue	$536,078	$113,188	$9,699	-
Cost Of Revenue	$536,078	$113,188	$9,699	-
Total Revenue	$1,844,966	$597,595	$69,343	$0
Operating Revenue	$1,844,966	$597,595	$69,343	$0
Expenses
Total Expenses	$1,757,966	$849,095	$239,793	$91,921
Operating Expense	$1,221,888	$735,907	$230,094	$91,921
General And Administrative Expense	$1,221,888	$735,907	$230,094	$91,921
Other Income Expense	-	-	-	$8,713
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$87,000	$-251,500	$-170,450	$-83,208
Normalized Income	$87,000	$-251,500	$-170,450	$-91,921
Net Income From Continuing And Discontinued Operation	$87,000	$-251,500	$-170,450	$-83,208
Total Operating Income As Reported	$87,000	$-251,500	$-170,450	$-91,921
Net Income Common Stockholders	$87,000	$-251,500	$-170,450	$-83,208
Net Income	$87,000	$-251,500	$-170,450	$-83,208
Net Income Including Noncontrolling Interests	$87,000	$-251,500	$-170,450	$-83,208
Net Income Continuous Operations	$87,000	$-251,500	$-170,450	$-83,208
Pretax Income	$87,000	$-251,500	$-170,450	$-83,208
Operating Income	$87,000	$-251,500	$-170,450	$-91,921
Gross Profit	$1,308,888	$484,407	$59,644	-
Special Income Charges	-	-	-	$8,713
Per Share
Diluted EPS	$0.00	$-0.04	$-0.16	$-0.08
Basic EPS	$0.00	$-0.04	$-0.16	$-0.08
Other
Tax Effect Of Unusual Items	$0	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$87,000	$-251,500	$-170,450	$-100,634
EBITDA (Bullshit earnings)	$87,000	$-251,500	$-170,450	$-91,921
EBIT	$87,000	$-251,500	$-170,450	$-91,921
Diluted Average Shares	$10,483,495	$8,441,168	$1,184,490	$1,365,375
Basic Average Shares	$10,483,495	$8,441,168	$1,184,490	$1,365,375
Diluted NI Availto Com Stockholders	$87,000	$-251,500	$-170,450	$-83,208
Selling General And Administration	$1,221,888	$735,907	$230,094	$91,921
Other Gand A	$1,221,888	$735,907	$230,094	$91,921
Total Unusual Items	-	-	-	$8,713
Total Unusual Items Excluding Goodwill	-	-	-	$8,713
Tax Provision	-	-	-	$0
Other Special Charges	-	-	-	$-8,713

Fetched: 2026-02-02

Balance Sheet (Annual)

Metric	2024-12-31	2023-12-31	2022-12-31	2022-08-31
Assets
Net Tangible Assets	$809,203	$-6,760	$-17,183	$14,393
Total Assets	$873,788	$93,388	$31,608	$16,253
Total Non Current Assets	$26,037	$0	$0	$0
Goodwill And Other Intangible Assets	$26,037	$0	-	-
Current Assets	$847,751	$93,388	$31,608	$16,253
Prepaid Assets	$26,630	$0	-	$0
Inventory	$58,319	$37,702	$12,278	-
Receivables	$100,285	$36,448	$7,761	-
Accounts Receivable	$100,285	$36,448	$7,761	-
Allowance For Doubtful Accounts Receivable	$0	$0	-	-
Gross Accounts Receivable	$100,285	$36,448	-	-
Cash Cash Equivalents And Short Term Investments	$662,517	$19,238	$11,569	$16,253
Cash And Cash Equivalents	$662,517	$19,238	$11,569	$16,253
Cash Financial	-	-	-	$16,253
Debt
Net Debt	-	-	-	-
Total Debt	-	-	-	-
Long Term Debt And Capital Lease Obligation	-	-	-	-
Long Term Debt	-	-	-	-
Current Debt And Capital Lease Obligation	-	-	-	-
Current Debt	-	-	-	-
Other Current Borrowings	-	-	-	-
Liabilities
Total Liabilities Net Minority Interest	$38,548	$100,148	$48,791	$1,860
Total Non Current Liabilities Net Minority Interest	$0	$0	$0	$0
Current Liabilities	$38,548	$100,148	$48,791	$1,860
Current Deferred Liabilities	$24,329	$3,949	$0	-
Payables And Accrued Expenses	$14,219	$96,199	$48,791	$1,860
Payables	$8,226	$94,749	$48,791	$1,860
Accounts Payable	$8,226	$7,675	$3,435	$1,860
Current Notes Payable	-	-	-	$0
Interest Payable	-	-	-	$0
Equity
Common Stock Equity	$835,226	$-6,774	$-17,197	$14,383
Preferred Stock Equity	$14	$14	$14	$10
Total Equity Gross Minority Interest	$835,240	$-6,760	$-17,183	$14,393
Stockholders Equity	$835,240	$-6,760	$-17,183	$14,393
Retained Earnings	$-341,083	$-428,083	$-176,583	$-117,400
Other
Ordinary Shares Number	$10,979,055	$10,224,055	$1,365,375	$1,365,375
Share Issued	$10,979,055	$10,224,055	$1,365,375	$1,365,375
Tangible Book Value	$809,189	$-6,774	$-17,197	$14,383
Invested Capital	$835,226	$-6,774	$-17,197	$14,383
Working Capital	$809,203	$-6,760	$-17,183	$14,393
Total Capitalization	$835,240	$-6,760	$-17,183	$14,393
Additional Paid In Capital	$1,171,918	$417,220	$158,840	$131,237
Capital Stock	$4,405	$4,103	$560	$556
Common Stock	$4,391	$4,089	$546	$546
Preferred Stock	$14	$14	$14	$10
Current Deferred Revenue	$24,329	$3,949	$0	-
Current Accrued Expenses	$5,993	$1,450	$0	$0
Dueto Related Parties Current	$0	$87,074	$45,356	-
Finished Goods	$58,319	$37,702	-	-

Fetched: 2026-02-02

Cash Flow Statement (Annual)

Metric	2024-12-31	2023-12-31	2022-12-31	2022-08-31
Free Cash Flow
Free Cash Flow	$-2,849	$-307,842	$-182,779	$-85,782
Operating Activities
Operating Cash Flow	$23,188	$-307,842	$-182,779	$-85,782
Cash Flow From Continuing Operating Activities	$23,188	$-307,842	$-182,779	$-85,782
Operating Gains Losses	-	-	-	$-8,713
Investing Activities
Capital Expenditure	$-26,037	-	-	-
Investing Cash Flow	$-26,037	$0	$0	-
Cash Flow From Continuing Investing Activities	$-26,037	$0	-	-
Financing Activities
Issuance Of Capital Stock	$755,000	$273,793	$150,000	$100,000
Financing Cash Flow	$646,128	$315,511	$194,248	$100,000
Cash Flow From Continuing Financing Activities	$646,128	$315,511	$194,248	$100,000
Net Other Financing Charges	$-108,872	$41,718	$44,248	-
Net Common Stock Issuance	$755,000	$273,793	$150,000	-
Common Stock Issuance	$755,000	$273,793	$150,000	-
Net Preferred Stock Issuance	-	-	-	$100,000
Preferred Stock Issuance	-	-	-	$100,000
Other
Interest Paid Supplemental Data	$0	$0	$0	$0
Income Tax Paid Supplemental Data	$0	$0	$0	$0
End Cash Position	$662,517	$19,238	$11,569	$16,253
Beginning Cash Position	$19,238	$11,569	$100	$2,035
Changes In Cash	$643,279	$7,669	$11,469	$14,218
Net Intangibles Purchase And Sale	$-26,037	$0	-	-
Purchase Of Intangibles	$-26,037	$0	-	-
Change In Working Capital	$-63,812	$-56,342	$-16,604	$6,139
Change In Other Working Capital	$20,380	$3,949	-	-
Change In Payables And Accrued Expense	$5,094	$-6,180	$3,435	$1,860
Change In Accrued Expense	$4,543	$1,450	$3,435	$0
Change In Payable	$551	$-7,630	-	$1,860
Change In Account Payable	$551	$-7,630	$0	$1,860
Change In Prepaid Assets	$-4,832	$0	-	$4,279
Change In Inventory	$-20,617	$-25,424	$-12,278	-
Change In Receivables	$-63,837	$-28,687	$-7,761	-
Changes In Account Receivables	$-63,837	$-28,687	$-7,761	-
Net Income From Continuing Operations	$87,000	$-251,500	$-170,450	$-83,208
Other Non Cash Items	-	-	$4,275	$-8,713
Repayment Of Debt	-	-	-	$0
Issuance Of Debt	-	-	-	$0
Net Issuance Payments Of Debt	-	-	-	$0
Net Short Term Debt Issuance	-	-	-	$0
Short Term Debt Issuance	-	-	-	$0
Net Long Term Debt Issuance	-	-	-	$0
Long Term Debt Payments	-	-	-	$0
Change In Interest Payable	-	-	-	$0
Long Term Debt Issuance	-	-	-	-

Fetched: 2026-02-02